← Leaderboards
James D Campbell
University Of Maryland Baltimore
$1,621,515
Attributed
$1,621,515
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $646.7K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$1,621,515 · 5
By mechanism
M01$1,621,515 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Myron Max Levine$22,681,817
- Marcela F Pasetti$26,884,335
- Karen Kotloff$13,373,636
- Christopher Darren Geddes$2,942,817
- Nicole Derr$1,570,113
Research focus
Computer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelInfluenzaResourcesGrantFundingInstitutionUnited States National Institutes Of HealthDoseSourceVaccinesResearch StudyUnited StatesIntramuscular InjectionsInfluenza, AvianInfluenza A Virus, AvianInfluenza Virus VaccineRangeDosageBaseHuman SubjectClinical Trial Phase IAsiaAluminum Hydroxide
Grant awards (6)
CVD INFLUENZA 17000: A PHASE I-II, RANDOMIZED, CONTROLLED, DOSE-RANGING STUDY$523,254
M01 · FY2007 · RR · contact PI
A PHASE I STUDY OF INACTIVATED VERO CELL-CULTURE INFLUENZA A/H5N1 GIVEN ALONE$89,781
M01 · FY2007 · RR · contact PI
INFLUENZA CVD 15000: EVALUATION OF A BOOSTER DOSE OF A/VIETNAM/1203/04 (H5N1)$33,668
M01 · FY2007 · RR · contact PI
CVD INFLUENZA 6000$457,503
M01 · FY2006 · RR · contact PI
PHASE IRPA ANTHRAX TRAIL$48,249
M01 · FY2005 · RR
Phase 1 rPA Anthrax Vaccine$469,060
M01 · FY2004 · RR